HRTX - Heron Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-12    (Delayed quote data   2025-01-06)
Last
 1.79		 Change
 ⇑ +0.13   (+7.83%)		 Volume
  2,425,892
Open
 1.64		 High
 1.83		 Low
 1.64
8EMA (Daily)
 1.63		 40EMA (Daily)
 1.58		 50EMA (Daily)
 1.61		 STO (Daily)
 52.402		 MACD Hist (Daily)
 0.035
8EMA (Weekly)
 1.621		 40EMA (Weekly)
 2.00		 50EMA (Weekly)
 2.07		 STO (Weekly)
 53.942		 MACD Hist (Weekly)
 0.080
Company Profile
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL and CINVANTI. Its pipeline product is HTX-011.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com